Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Precipio
AddedFeb 19, 2024
UpdatedJul 5, 2026
Precipio

Precipio

Public

Precipio: A leading cancer diagnostics lab, providing expert advice for optimal patient care.

HQ
New Haven, CT, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer diagnostics, Precipio aims to provide the most accurate and efficient diagnostic advice to enhance patient care. The company offers proprietary hematology diagnostic products, including Bloodhound™ and HemeScreen® molecular kits, which detect various mutations related to blood cancers like MPN, CLL, and AML. Precipio focuses on improving laboratory throughput and economics while ensuring superior diagnostic accuracy for patients and physicians.

Precipio has garnered attention for its innovative approach to cancer diagnostics, attracting notable investors and partnerships within the medical and biotech sectors. The company's achievements include the development of advanced diagnostic tools that significantly enhance the speed and accuracy of hematology testing. By prioritizing precision and efficiency, Precipio has made a substantial impact on the quality of cancer diagnostics, ultimately contributing to better patient outcomes.

Precipio - Similar Companies

Torpedo Diagnostics logo

Torpedo Diagnostics

Foundation Medicine logo

Foundation Medicine

Accelerated Medical Diagnostics logo

Accelerated Medical Diagnostics

Exact Sciences logo

Exact Sciences

exactsciences.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

Empowered Diagnostics logo

Empowered Diagnostics

CDx Diagnostics logo

CDx Diagnostics

Guardant Health logo

Guardant Health

guardanthealth.com

Avant Diagnostics logo

Avant Diagnostics

Acuamark Diagnostics logo

Acuamark Diagnostics

acuamarkdx.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Oncocyte logo

Oncocyte

oncocyte.com

Castle Biosciences logo

Castle Biosciences

Eventus Diagnostics logo

Eventus Diagnostics

Precipio - Quick Facts

Who are Precipio's competitors?

Companies similar to Precipio include Torpedo Diagnostics, Foundation Medicine, Accelerated Medical Diagnostics and Exact Sciences.

When was Precipio founded?

Precipio was founded in 2011.

Where is Precipio's headquarters located?

Precipio's headquarters is located in New Haven, CT, US.

When was Precipio's last funding round?

Precipio's most recent funding round was for $400k (USD) in July 2017.

How much has Precipio raised to-date?

As of Jul 14, 2017, Precipio has raised a total of $3.3M (USD).

How many employees does Precipio have?

Precipio has 68 employees as of Feb 6, 2024.

Precipio - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Diagnostics
Tags
  • Data
  • Healthtech
Unique IDs
  • secCik: 0001043961
  • ticker: PRPO
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 7210Research and experimental development on natural sciences and engineering